Document is current
Any future updates will be listed below
-
Authors
Mizuno, Toshiyuki https://orcid.org/0009-0008-3969-0068
Tsukamoto, Manabu https://orcid.org/0000-0003-4577-5072
Teramoto, Hidefumi
Hamasaki, Takahiko https://orcid.org/0009-0000-9562-7487
Shirakawa, Taizan
Nakagawa, Tsuyoshi
Yamasaki, Takuma
Tsukisaka, Junya https://orcid.org/0009-0008-3405-5292
Adachi, Nobuo https://orcid.org/0000-0002-5570-3729
Fujiwara, Saeko https://orcid.org/0000-0002-0114-5266
Okimoto, Nobukazu https://orcid.org/0000-0001-5323-0350
-
Funding
Funding for this research was provided by:
Grant-in-Aid for Science Research from the Japanese Osteoporosis Society
The JSBMR Rising Stars Grant
- License Information
-
More Information
Article History
Received: 22 September 2025
Accepted: 6 February 2026
First Online: 19 February 2026
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committees and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Formal consent was not required for this type of study.
: M. Tsukamoto has received payments for lectures from Asahi Kasei Pharma Corporation. MT has received consulting fees from Zimmer Biomet G.K. T. Hamasaki has received lecture fees from Asahi Kasei Pharma Corporation, Amgen K. K., Daiichi Sankyo Co., Ltd., Mochida Pharmaceutical Co., Ltd., and Teijin Pharma Ltd. S. Fujiwara received consulting fees from Asahi Kasei Pharma Corporation, Teijin Parma Ltd., UCB Japan Co., Ltd., Amgen K.K. and GE Healthcare Japan and supervision fees from Medical Data Card, Inc. N. Okimoto received consulting fees from Asahi Kasei Pharma Corporation, Amgen K. K., Daiichi Sankyo Co., Ltd., and Teijin Pharma Ltd. T. Mizuno, H. Teramoto, T. Shirakawa, T. Nakagawa, J. Tsukisaka and N. Adachi declare that they have no conflicts of interest.
